Abiopharma

🔍 Schaffer Shane J. (Director)

Company: Cingulate Inc. (CING)

Report Date: 2026-03-09

Detailed Transactions and Holdings:

• Acquired 6,862 shares of Common Stock (Direct)
  Date: 2026-03-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 7,035.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,959 shares of Common Stock (Direct)
  Date: 2026-03-09 | Code: F | equity_swap_involved: 0 | shares_owned_after: 4,076.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-09 | Code: H | nature_of_ownership: By Fountainhead Shrugged, LLC | shares_owned_after: 10,175.00 | Footnotes: F3

Footnotes:

• F1: Shares of common stock were granted pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended, for a portion of the Reporting Person's 2025 bonus.
• F2: Shares otherwise issuable were withheld to satisfy the Reporting Person's tax obligations on the grant described in footnote 1 above.
• F3: Reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.